Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CHE Transcript
Chemed Corporation (CHE) Presents at UBS Global Healthcare Conference 2025 Transcript
Neutral11-11
Chemed Corporation (CHE) Q3 2025 Earnings Call Transcript
Unknown10-29
The earnings call highlights mixed results: strong revenue growth projections for VITAS in 2025, but declining EBITDA margins in both VITAS and Roto-Rooter. Management's optimism about future margin improvements and revenue growth is offset by current financial declines and vague guidance for 2026. The Q&A session reveals concerns about elevated DSO and unclear responses on strategic improvements. Overall, these factors suggest a neutral sentiment, with no strong catalysts for significant stock price movement in the next two weeks.
Chemed Corporation (CHE) Q2 2025 Earnings Call Transcript
Unknown7-30
The earnings call presents a mixed picture. Positive elements include VITAS's revenue growth and strategic acquisitions, while negative aspects involve declining Roto-Rooter EBITDA and margin concerns. The Q&A session revealed management's efforts to address issues but also highlighted uncertainties, particularly with Roto-Rooter and VITAS admissions. The lack of detailed guidance and unclear responses create uncertainty, balancing the positive impact of share buybacks and strategic focus. Overall, the sentiment is neutral as the positive and negative factors counterbalance each other, leading to an expected stock price movement within the -2% to 2% range.
Chemed at BofA Securities Conference: Strategic Insights on VITAS and Roto-Rooter
Neutral5-14
CHE Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
